Plus Therapeutics appoints Eric J. Daniels as CDO; base salary $460K, equity grant

PLUS THERAPEUTICS, INC.

Daniels becomes Chief Development Officer effective April 20, 2026, reporting to CEO.
Prior role: Chief Development Officer at Kiora Pharmaceuticals (NASDAQ:KPRX) from Oct 2021 to Apr 2026.
Initial annual base salary of $460,000; target bonus of 40% of base salary.
Equity inducement: option for 20,000 shares vesting over 4 years (1-yr cliff) and 20,000 RSUs vesting over 3 years.
Severance on involuntary termination: 12 months' salary plus target bonus, plus vesting acceleration on 9 months of unvested equity.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.